Intervention Review

Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma

  1. Chris Williams1,*,
  2. Andrew Bryant2

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 11 MAY 2011

Assessed as up-to-date: 11 APR 2011

DOI: 10.1002/14651858.CD003911.pub2


How to Cite

Williams C, Bryant A. Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma. Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD003911. DOI: 10.1002/14651858.CD003911.pub2.

Author Information

  1. 1

    Royal United Hospital, Cochrane Gynaecological Cancer Review Group, Bath, UK

  2. 2

    Newcastle University, Institute of Health & Society, Newcastle upon Tyne, UK

*Chris Williams, Cochrane Gynaecological Cancer Review Group, Royal United Hospital, Combe Park, Bath, BA1 3NG, UK. chrisjhwilliams@btinternet.com.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 11 MAY 2011

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.